150 results on '"Imamura, Masakazu"'
Search Results
2. Use of proton pump inhibitors is associated with an increase in adverse cardiovascular events in patients with hemodialysis: Insight from the kids registry
3. Antidiabetic and antiobesity effects of SGLT2 inhibitor ipragliflozin in type 2 diabetic mice fed sugar solution
4. Characterization and comparison of SGLT2 inhibitors: Part 3. Effects on diabetic complications in type 2 diabetic mice
5. Characterization and comparison of sodium-glucose cotransporter 2 inhibitors: Part 2. Antidiabetic effects in type 2 diabetic mice
6. Characterization and comparison of sodium-glucose cotransporter 2 inhibitors in pharmacokinetics, pharmacodynamics, and pharmacologic effects
7. The Kagoshima-DVT Score Is a Useful Predictive Model for Cancer-Associated Thrombosis in Patients With Gastrointestinal Cancer
8. Effects of SGLT2 selective inhibitor ipragliflozin on hyperglycemia, hyperlipidemia, hepatic steatosis, oxidative stress, inflammation, and obesity in type 2 diabetic mice
9. Synthesis and biological evaluation of C-glucosides with azulene rings as selective SGLT2 inhibitors for the treatment of type 2 diabetes mellitus: Discovery of YM543
10. Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice
11. Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus
12. Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin–Nicotinamide-Induced Mildly Diabetic Mice
13. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant
14. NKT Cells Prevent Chronic Joint Inflammation after Infection with Borrelia burgdorferi
15. Prognostic impact of blood vessel invasion in gastrointestinal stromal tumor of the stomach
16. Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo
17. Expression level of the mitotic checkpoint protein and G2–M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach
18. Natural Sphingomonas Glycolipids Vary Greatly in Their Ability to Activate Natural Killer T Cells
19. Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats
20. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q
21. Proctocolectomy for colon cancer associated with ulcerative colitis a few months after living donor liver transplantation for primary sclerosing cholangitis: Report of a case
22. Prognostic significance of angiogenesis in gastrointestinal stromal tumor
23. INVESTIGATION OF THE CLINICAL FACTOR ASSOCIATED WITH INTRADIALYTIC HYPOTENSION: INSIGHT FROM KIDS REGISTRY
24. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade
25. Management instructions for elderly patients with hypertension
26. Management instructions for elderly patients with hypertension.
27. Quantitative microarray analysis of intact glycolipid-CD1d interaction and correlation with cell-based cytokine production
28. Questionnaire Survey From the Viewpoint of Concordance in Patient and Physician Satisfaction Concerning Hypertensive Treatment in Elderly Patients ― Patients Voice Study ―
29. Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice
30. Peripartum cardiomyopathy in a patient with Graves' disease
31. Primary gastrointestinal stromal tumor of the liver with PDGFRA gene mutation
32. Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor
33. Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin^|^ndash;Nicotinamide-Induced Mildly Diabetic Mice
34. Left Ventricular Dysfunction Assessed by Cardiac Time Interval Analysis Among Different Geometric Patterns in Untreated Hypertension
35. Expression level of the mitotic checkpoint protein and G2–M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach
36. Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo
37. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria
38. 114. Aspects of water status of various organs in drought tolerant cowpea plants exposed to drought stress compared with the common bean
39. Neurofibromatosis type 1-related gastrointestinal stromal tumors: a special reference to loss of heterozygosity at 14q and 22q
40. Quantitative Microarray Analysis of Intact Glycolipid−CD1d Interaction and Correlation with Cell-Based Cytokine Production
41. The antigenic activity of glycosphingolipids with tetrasaccharide sugars from Sphingomonas bacteria to natural killer T cells
42. Isolation and characterization of a cDNA coding cowpea (Vigna unguiculata (L.) Walp.) calcineurin B-like protein-interacting protein kinase, VuCIPK1
43. (+)-(2R,5S)-4-[4-Cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an Orally Potent and Peripherally Selective Nonsteroidal Androgen Receptor Antagonist
44. Effects of sauna therapy on cardiac arrhythmia in patients with chronic heart failure
45. Repeated sauna treatment improves vascular endothelial and cardiac function in patients with chronic heart failure
46. Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors
47. Synthesis of novel CMP-NeuNAc analogues having a glycosyl phosphonate structure
48. Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.
49. Stereoselective Synthesis of C-Allyl-N-acetylglucosaminide
50. (+)-(11,60)-4-[4-Cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an Orally Potent and Peripherally Selective Nonsteroidal Androgen Receptor Antagonist1
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.